Trial Profile
Evaluation of Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation by Single Administration in Chinese Patients With Schizophrenia: a Single-center, Uncontrolled, Open -Label Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- 16 Jan 2020 Status changed from recruiting to completed.
- 20 Feb 2019 Planned End Date changed from 1 Mar 2019 to 1 Jul 2019.
- 20 Feb 2019 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.